Small intestinal follicular lymphoma induced by methotrexate: a case report.
Case report
Follicular lymphoma
Ileum
Lymphoproliferative disorder
Methotrexate
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
08 Jul 2021
08 Jul 2021
Historique:
received:
16
01
2021
accepted:
21
06
2021
entrez:
9
7
2021
pubmed:
10
7
2021
medline:
13
7
2021
Statut:
epublish
Résumé
Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is a rare but critical complication that develops in patients treated with MTX. Although MTX-LPD has been recently reported, the incidence of follicular lymphoma in the intestine is very low. A 73-year-old woman who had been receiving MTX for over 10 years visited our hospital complaining of postprandial abdominal pain and nausea. Upper and lower digestive tract endoscopies did not show any abnormal findings. A patency capsule was stagnated at the proximal part of the ileum with a mild dilation on the oral side. An oral balloon endoscopy revealed shallow ulcerative lesions in the jejunum. She was diagnosed with MTX-LPD based on histopathological findings. The symptoms did not improve with the discontinuation of MTX, and the patient required partial resection of the small intestine. The test result for Epstein-Barr virus-encoded small RNA was negative. She was diagnosed with follicular lymphoma based on the histology findings of a surgical specimen. Postoperative positron emission tomography-computed tomography and bone marrow aspiration did not show any findings of lymphoma. On follow-up, no recurrence was noted four years after the surgery. Herein, we report the first case of follicular lymphoma that occurred in the small intestine, negative for Epstein-Barr virus-encoded small RNA. If intestinal symptoms occur during MTX administration, it is important to directly observe by endoscopy and perform histological examination.
Sections du résumé
BACKGROUND
BACKGROUND
Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is a rare but critical complication that develops in patients treated with MTX. Although MTX-LPD has been recently reported, the incidence of follicular lymphoma in the intestine is very low.
CASE PRESENTATION
METHODS
A 73-year-old woman who had been receiving MTX for over 10 years visited our hospital complaining of postprandial abdominal pain and nausea. Upper and lower digestive tract endoscopies did not show any abnormal findings. A patency capsule was stagnated at the proximal part of the ileum with a mild dilation on the oral side. An oral balloon endoscopy revealed shallow ulcerative lesions in the jejunum. She was diagnosed with MTX-LPD based on histopathological findings. The symptoms did not improve with the discontinuation of MTX, and the patient required partial resection of the small intestine. The test result for Epstein-Barr virus-encoded small RNA was negative. She was diagnosed with follicular lymphoma based on the histology findings of a surgical specimen. Postoperative positron emission tomography-computed tomography and bone marrow aspiration did not show any findings of lymphoma. On follow-up, no recurrence was noted four years after the surgery.
CONCLUSIONS
CONCLUSIONS
Herein, we report the first case of follicular lymphoma that occurred in the small intestine, negative for Epstein-Barr virus-encoded small RNA. If intestinal symptoms occur during MTX administration, it is important to directly observe by endoscopy and perform histological examination.
Identifiants
pubmed: 34238226
doi: 10.1186/s12876-021-01849-8
pii: 10.1186/s12876-021-01849-8
pmc: PMC8268449
doi:
Substances chimiques
Methotrexate
YL5FZ2Y5U1
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
280Références
J Clin Exp Hematop. 2019;59(2):72-92
pubmed: 31257348
Blood. 2002 Jun 1;99(11):3909-15
pubmed: 12010788
Intern Med. 2016;55(16):2259-64
pubmed: 27523005
Am J Hematol. 2007 Dec;82(12):1106-9
pubmed: 17654684
BMC Gastroenterol. 2019 Apr 25;19(1):62
pubmed: 31023238
Mod Pathol. 2009 Dec;22(12):1532-40
pubmed: 19767727
J Rheumatol. 2007 Feb;34(2):322-31
pubmed: 17117491
Am J Pathol. 1988 Oct;133(1):173-92
pubmed: 2845789
Mol Pathol. 2000 Oct;53(5):248-54
pubmed: 11091848
Eur J Haematol. 2013 Jul;91(1):20-8
pubmed: 23560463
J Clin Exp Hematop. 2019;59(4):145-155
pubmed: 31866617
Ann Rheum Dis. 2017 Jun;76(6):960-977
pubmed: 28264816
Arthritis Rheum. 2004 Jun;50(6):1740-51
pubmed: 15188349